CoDon AG banner

Intrinsic Value

Not Available for 0Q37

There is not enough data to reliably calculate the intrinsic value for CoDon AG.

Do our valuations actually work? See backtest results .

Alternatives to 0Q37

Fundamental Analysis

What CoDon Does

Biotechnology Health Care

co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage defects. The firm develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders.

Headquarters
Germany DE
Employees
134
IPO date
Feb 1, 2001
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
CoDon AG

Efficiency

Earnings Waterfall
CoDon AG

Wall St Price Targets

Capital Returns

Competitive Landscape